Divalency and Trivalency

2012
E. T. Mack, P. W. Snyder, R. Perez-Castillejos, B. Bilgicer, D. T. Moustakas, M. J. Butte, and G. M. Whitesides. 2012. “Dependence of Avidity on Linker Length for a Bivalent Ligand-Bivalent Receptor Model System.” J. Amer. Chem. Soc., 134, Pp. 333-345.Abstract
PMCID:PMC3272676
PDF Supplemental
1138
2008
E. T. Mack, R. Perez-Castillejos, Z. Suo, and G. M. Whitesides. 2008. “Exact Analysis of Ligand-Induced Dimerization of Momomeric Receptors.” Analytical Chemistry, 80, Pp. 5550-5555. PDF
1023
2006
V.M. Krishnamurthy, L. A. Estroff, and G. M. Whitesides. 2006. “Multivalency in Ligand Design.” In Fragment-based Approaches in Drug Discovery, edited by R. Mannhold, H. Kubinyi, and G. Folkers, 34: Pp. 11-53. Weinheim: WILEY-VCH Verlag GmbH & Co. 963.pdf
963
1998
M. Mammen, S.-K. Choi, and G. M. Whitesides. 1998. “Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.” Angew. Chem. Int. Ed. Engl., 37, Pp. 2755-2794. PDF
598
J. Rao, J. Lahiri, L. Isaacs, R. M. Weis, and G. M. Whitesides. 1998. “A Trivalent System from Vancomycin•D-Ala-D-Ala with Higher Affinity Than Avidin•Biotin.” Science, 280, Pp. 708-711. PDF
614
1997
J. Rao and G. M. Whitesides. 1997. “Tight Binding of a Dimeric Derivative of Vancomycin with Dimeric L-Lys-D-Ala-D-Ala.” J. Am. Chem. Soc., 119, Pp. 10286-10290. PDF
576
J. Rao, I. J. Colton, and G. M. Whitesides. 1997. “Using Capillary Electrophoresis to Study the Electrostatic Interactions Involved in the Association of D-Ala-D-Ala with Vancomycin.” J. Am. Chem. Soc., 119, Pp. 9336-9340. PDF
575